[1] KUMAR R, LIM J, MEKARY RA, et al. Traumatic spinal injury: global epidemiology and worldwide volume. World Neurosurg. 2018;113: e345-e363.
[2] AHUJA CS, WILSON JR, NORI S, et al. Traumatic spinal cord injury. Nat Rev Dis Primers. 2017;3:17018.
[3] PRIEBE MM, CHIODO AE, SCELZA WM, et al. Spinal cord injury medicine. 6. Economic and societal issues in spinal cord injury. Arch Phys Med Rehabil. 2007;88(3 Suppl 1):S84-S88.
[4] LONDON A, COHEN M, SCHWARTZ M. Microglia and monocyte-derived macrophages: functionally distinct populations that act in concert in CNS plasticity and repair. Front Cell Neurosci. 2013;7:34.
[5] JIN X, LIU MY, ZHANG DF, et al. Natural products as a potential modulator of microglial polarization in neurodegenerative diseases. Pharmacol Res. 2019;145:104253.
[6] MEDZHITOV R. Origin and physiological roles of inflammation. Nature. 2008;454(7203):428-435.
[7] DAVID S, KRONER A. Repertoire of microglial and macrophage responses after spinal cord injury. Nat Rev Neurosci. 2011;12(7):388-399.
[8] JURGA AM, PALECZNA M, KUTER KZ. Overview of general and discriminating markers of differential microglia phenotypes. Front Cell Neurosci. 2020;14:198.
[9] KIERDORF K, ERNY D, GOLDMANN T, et al. Microglia emerge from erythromyeloid precursors via Pu.1- and Irf8-dependent pathways. Nat Neurosci. 2013;16(3):273-280.
[10] XU L, HE D, BAI Y. Microglia-Mediated Inflammation and Neurodegenerative Disease. Mol Neurobiol. 2016;53(10):6709-6715.
[11] GAUDET AD, FONKEN LK. Glial cells shape pathology and repair after spinal cord injury. Neurotherapeutics. 2018;15(3):554-577.
[12] HAGEMEYER N, HANFT KM, AKRIDITOU MA, et al. Microglia contribute to normal myelinogenesis and to oligodendrocyte progenitor maintenance during adulthood. Acta Neuropathol. 2017;134(3):441-458.
[13] YANG Z, LIU B, YANG LE, et al. Platycodigenin as potential drug candidate for alzheimer’s disease via modulating microglial polarization and neurite regeneration. Molecules. 2019. doi: 10.3390/molecules24183207.
[14] MILICH LM, RYAN CB, LEE JK. The origin, fate, and contribution of macrophages to spinal cord injury pathology. Acta Neuropathol. 2019; 137(5):785-797.
[15] KIGERL KA, LAI W, WALLACE LM, et al. High mobility group box-1 (HMGB1) is increased in injured mouse spinal cord and can elicit neurotoxic inflammation. Brain Behav Immun. 2018;72:22-33.
[16] KIGERL KA, GENSEL JC, ANKENY DP, et al. Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J Neurosci. 2009; 29(43):13435-13444.
[17] ORTEGA-GóMEZ A, PERRETTI M, SOEHNLEIN O. Resolution of inflammation: an integrated view. EMBO Mol Med. 2013;5(5):661-674.
[18] SHAPOURI-MOGHADDAM A, MOHAMMADIAN S, VAZINI H, et al. Macrophage plasticity, polarization, and function in health and disease. J Cell Physiol. 2018;233(9):6425-6440.
[19] FENN AM, HALL JC, GENSEL JC, et al. IL-4 signaling drives a unique arginase+/IL-1β+ microglia phenotype and recruits macrophages to the inflammatory CNS: consequences of age-related deficits in IL-4Rα after traumatic spinal cord injury. J Neurosci. 2014;34(26):8904-8917.
[20] LITTLEFIELD A, KOHMAN RA. Differential response to intrahippocampal interleukin-4/interleukin-13 in aged and exercise mice. Neuroscience. 2017;343:106-114.
[21] MARTINEZ FO, SICA A, MANTOVANI A, et al. Macrophage activation and polarization. Front Biosci. 2008;13:453-461.
[22] ORIHUELA R, MCPHERSON CA, HARRY GJ. Microglial M1/M2 polarization and metabolic states. Br J Pharmacol. 2016;173(4):649-665.
[23] EHRCHEN J, STEINMüLLER L, BARCZYK K, et al. Glucocorticoids induce differentiation of a specifically activated, anti-inflammatory subtype of human monocytes. Blood. 2007;109(3):1265-1274.
[24] LI XH, FU NS, XING ZM. MiR-100 suppresses inflammatory activation of microglia and neuronal apoptosis following spinal cord injury via TLR4/NF-κB pathway. Eur Rev Med Pharmacol Sci. 2019;23(20):8713-8720.
[25] FATIMA G, SHARMA VP, DAS SK, et al. Oxidative stress and antioxidative parameters in patients with spinal cord injury: implications in the pathogenesis of disease. Spinal Cord. 2015;53(1):3-6.
[26] SONG C, HEPING H, SHEN Y, et al. AMPK/p38/Nrf2 activation as a protective feedback to restrain oxidative stress and inflammation in microglia stimulated with sodium fluoride. Chemosphere. 2020; 244:125495.
[27] WU J, DING DH, LI QQ, et al. Lipoxin A4 regulates lipopolysaccharide-induced bv2 microglial activation and differentiation via the notch signaling pathway. Front Cell Neurosci. 2019;13:19.
[28] VEZZANI A and VIVIANI B. Neuromodulatory properties of inflammatory cytokines and their impact on neuronal excitability. Neuropharmacology. 2015;96(Pt A):70-82.
[29] KITAYAMA M, UENO M, ITAKURA T, et al. Activated microglia inhibit axonal growth through RGMa. PLoS One. 2011;6(9):e25234.
[30] LIDDELOW SA, GUTTENPLAN KA, CLARKE LE, et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature. 2017; 541(7638):481-487.
[31] ANDERSON MA, BURDA JE, REN Y, et al. Astrocyte scar formation aids central nervous system axon regeneration. Nature. 2016;532(7598): 195-200.
[32] WEINHARD L, DI BARTOLOMEI G, BOLASCO G, et al. Microglia remodel synapses by presynaptic trogocytosis and spine head filopodia induction. Nat Commun. 2018;9(1):1228.
[33] PAOLICELLI RC, BOLASCO G, PAGANI F, et al. Synaptic pruning by microglia is necessary for normal brain development. Science. 2011; 333(6048):1456-1458.
[34] ROMERO-SANCHIZ P, NOGUEIRA-ARJONA R, ARAOS P, et al. Variation in chemokines plasma concentrations in primary care depressed patients associated with Internet-based cognitive-behavioral therapy. Sci Rep. 2020;10(1):1078.
[35] OUDEGA M. Molecular and cellular mechanisms underlying the role of blood vessels in spinal cord injury and repair. Cell Tissue Res. 2012;349(1):269-288.
[36] JIN S, YANG C, HUANG J, et al. Conditioned medium derived from FGF-2-modified GMSCs enhances migration and angiogenesis of human umbilical vein endothelial cells. Stem Cell Res Ther. 2020;11(1):68.
[37] MUNIR H, WARD LSC, MCGETTRICK HM. Mesenchymal stem cells as endogenous regulators of inflammation. Adv Exp Med Biol. 2018;1060: 73-98.
[38] IN’T ANKER PS, SCHERJON SA, KLEIJBURG-VAN DER KEUR C, et al. Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells. 2004;22(7):1338-1345.
[39] NAKAJIMA H, UCHIDA K, GUERRERO AR, et al. Transplantation of mesenchymal stem cells promotes an alternative pathway of macrophage activation and functional recovery after spinal cord injury. J Neurotrauma. 2012;29(8):1614-1625.
[40] SUN J, LIU YL, LI C, et al. Effect of human adipose mesenchymal stem cells on phenotype polarization of mice microglia via TLR3/TRIF signal pathway. Sichuan Da Xue Xue Bao Yi Xue Ban. 2019;50(2):164-170.
[41] CHO DI, KIM MR, JEONG HY, et al. Mesenchymal stem cells reciprocally regulate the M1/M2 balance in mouse bone marrow-derived macrophages. Exp Mol Med. 2014;46(1):e70.
[42] DE BECKER A and RIET IV. Homing and migration of mesenchymal stromal cells: How to improve the efficacy of cell therapy? World J Stem Cells. 2016;8(3):73-87.
[43] RODRIGUEZ R, RUBIO R, MENENDEZ P. Modeling sarcomagenesis using multipotent mesenchymal stem cells. Cell Res. 2012;22(1):62-77.
[44] ORTEGA FG, ROEFS MT, DE MIGUEL PEREZ D, et al. Interfering with endolysosomal trafficking enhances release of bioactive exosomes. Nanomedicine. 2019;20:102014.
[45] MATHIVANAN S, JI H, SIMPSON RJ. Exosomes: extracellular organelles important in intercellular communication. J Proteomics. 2010;73(10): 1907-1920.
[46] FARAHANI M, RUBBI C, LIU L, et al. CLL exosomes modulate the transcriptome and behaviour of recipient stromal cells and are selectively enriched in miR-202-3p. PLoS One. 2015;10(10):e0141429.
[47] GALLART-PALAU X, SERRA A, SZE SK. Enrichment of extracellular vesicles from tissues of the central nervous system by PROSPR. Mol Neurodegener. 2016;11(1):41.
[48] SUN G, LI G, LI D, et al. hucMSC derived exosomes promote functional recovery in spinal cord injury mice via attenuating inflammation. Mater Sci Eng C Mater Biol Appl. 2018;89:194-204.
[49] LIU W, RONG Y, WANG J, et al. Exosome-shuttled miR-216a-5p from hypoxic preconditioned mesenchymal stem cells repair traumatic spinal cord injury by shifting microglial M1/M2 polarization. J Neuroinflammation. 2020;17(1):47.
[50] SHAO M, JIN M, XU S, et al. Exosomes from long noncoding RNA-Gm37494-ADSCs repair spinal cord injury via shifting microglial M1/M2 polarization. Inflammation. 2020;43(4):1536-1547.
[51] CERQUEIRA SR, OLIVEIRA JM, SILVA NA, et al. Microglia response and in vivo therapeutic potential of methylprednisolone-loaded dendrimer nanoparticles in spinal cord injury. Small. 2013;9(5):738-749.
[52] CHEN S, YE J, CHEN X, et al. Valproic acid attenuates traumatic spinal cord injury-induced inflammation via STAT1 and NF-κB pathway dependent of HDAC3. J Neuroinflammation. 2018;15(1):150.
[53] ZHANG Y, LIU Z, ZHANG W, et al. Melatonin improves functional recovery in female rats after acute spinal cord injury by modulating polarization of spinal microglial/macrophages. J Neurosci Res. 2019; 97(7):733-743.
[54] WU Q, ZHANG Y, ZHANG Y, et al. Riluzole improves functional recovery after acute spinal cord injury in rats and may be associated with changes in spinal microglia/macrophages polarization. Neurosci Lett. 2020;723:134829.
[55] WANG L, WU JP, HE XJ. Butylphthalide has an anti-inflammatory role in spinal cord injury by promoting macrophage/microglia M2 polarization via p38 phosphorylation. Spine (Phila Pa 1976). 2020;45(17): E1066-E1076.
[56] HENKEL T, BRUNNE RM, MüLLER H, et al. Statistical investigation into the structural complementarity of natural products and synthetic compounds. Angew Chem Int Ed Engl. 1999;38(5):643-647.
[57] KUBOYAMA T, KOMINATO S, NAGUMO M, et al. Recovery from spinal cord injury via M2 microglial polarization induced by Polygalae Radix. Phytomedicine. 2021;82:153452.
[58] CHEN F, HU M, SHEN Y, et al. Isorhamnetin promotes functional recovery in rats with spinal cord injury by abating oxidative stress and modulating M2 macrophages/microglia polarization. Eur J Pharmacol. 2021;895:173878.
[59] LIN J, PAN X, HUANG C, et al. Dual regulation of microglia and neurons by Astragaloside IV-mediated mTORC1 suppression promotes functional recovery after acute spinal cord injury. J Cell Mol Med. 2020;24(1):671-685.
[60] SU XQ, WANG XY, GONG FT, et al. Oral treatment with glycyrrhizin inhibits NLRP3 inflammasome activation and promotes microglial M2 polarization after traumatic spinal cord injury. Brain Res Bull. 2020; 158:1-8.
[61] XIAO S, WANG C, YANG Q, et al. Rea regulates microglial polarization and attenuates neuronal apoptosis via inhibition of the NF-κB and MAPK signalings for spinal cord injury repair. J Cell Mol Med. 2021; 25(3):1371-1382.
[62] SUBRAMANIAM S, JEET V, CLEMENTS JA, et al. Emergence of microRNAs as key players in cancer cell metabolism. Clin Chem. 2019; 65(9):1090-1101.
[63] ENGELS BM, HUTVAGNER G. Principles and effects of microRNA-mediated post-transcriptional gene regulation. Oncogene. 2006;25(46): 6163-6169.
[64] PARK JH, SHIN C. MicroRNA-directed cleavage of targets: mechanism and experimental approaches. BMB Rep. 2014;47(8):417-423.
[65] CHEN Y, SUN JX, CHEN WK, et al. miR-124/VAMP3 is a novel therapeutic target for mitigation of surgical trauma-induced microglial activation. Signal Transduct Target Ther. 2019;4:27.
[66] GUO Y, HONG W, WANG X, et al. MicroRNAs in microglia: how do MicroRNAs affect activation, inflammation, polarization of microglia and mediate the interaction between microglia and glioma? Front Mol Neurosci. 2019;12:125.
[67] HAMZEI TAJ S, KHO W, RIOU A, et al. MiRNA-124 induces neuroprotection and functional improvement after focal cerebral ischemia. Biomaterials. 2016;91:151-165.
[68] YANG Z, XU J, ZHU R, et al. Down-regulation of miRNA-128 contributes to neuropathic pain following spinal cord injury via activation of p38. Med Sci Monit. 2017;23:405-411.
[69] BERMUDEZ S, KHAYRULLINA G, ZHAO Y, et al. NADPH oxidase isoform expression is temporally regulated and may contribute to microglial/macrophage polarization after spinal cord injury. Mol Cell Neurosci. 2016;77:53-64.
[70] ANTONIOLI L, PACHER P, VIZI ES, et al. CD39 and CD73 in immunity and inflammation. Trends Mol Med. 2013;19(6):355-367.
[71] XU S, ZHU W, SHAO M, et al. Ecto-5’-nucleotidase (CD73) attenuates inflammation after spinal cord injury by promoting macrophages/microglia M2 polarization in mice. J Neuroinflammation. 2018; 15(1):155.
[72] KONG F, SUN K, ZHU J, et al. PD-L1 improves motor function and alleviates neuropathic pain in male mice after spinal cord injury by inhibiting MAPK pathway. Front Immunol. 2021;12:670646.
[73] WANG J, CHEN J, JIN H, et al. BRD4 inhibition attenuates inflammatory response in microglia and facilitates recovery after spinal cord injury in rats. J Cell Mol Med. 2019;23(5):3214-3223.
[74] KWON BK, TETZLAFF W, GRAUER JN, et al. Pathophysiology and pharmacologic treatment of acute spinal cord injury. Spine J. 2004;4(4): 451-464.
[75] AMBROZAITIS KV, KONTAUTAS E, SPAKAUSKAS B, et al. Pathophysiology of acute spinal cord injury. Medicina (Kaunas). 2006;42(3):255-261.
[76] ZHANG X, MOSSER DM. Macrophage activation by endogenous danger signals. J Pathol. 2008;214(2):161-178.
[77] GENSEL JC, ZHANG B. Macrophage activation and its role in repair and pathology after spinal cord injury. Brain Res. 2015;1619:1-11.
[78] HAGGERTY AE, MALDONADO-LASUNCIóN I, OUDEGA M. Biomaterials for revascularization and immunomodulation after spinal cord injury. Biomed Mater. 2018;13(4):044105.
[79] MALDONADO-LASUNCIóN I, VERHAAGEN J, OUDEGA M. Mesenchymal stem cell-macrophage choreography supporting spinal cord repair. Neurotherapeutics. 2018;15(3):578-587.
[80] SHECHTER R, SCHWARTZ M. CNS sterile injury: just another wound healing? Trends Mol Med. 2013;19(3):135-143.
|